Zoetis (ZTS) Inventory Average (2013 - 2026)
Zoetis' (ZTS) quarterly Inventory Average came in at $2.5 billion in Q1 2026, up 7.34% year-on-year from $2.3 billion in Q1 2025, and up 1.72% on a QoQ basis from $2.5 billion in Q4 2025.
Zoetis (ZTS) Inventory Average (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has 14 years of Inventory Average data on file, last reported at $2.5 billion in Q1 2026.
- On a quarterly basis, Inventory Average rose 7.34% year-over-year to $2.5 billion in Q1 2026; TTM through Mar 2026 was $2.5 billion, a 7.34% increase from a year earlier, with the FY2025 full-year figure at $2.4 billion, down 2.05% from the prior year.
- Inventory Average for Q1 2026 stood at $2.5 billion, up from $2.5 billion in the prior quarter.
- Over the last five years, Inventory Average for ZTS reached as high as $2.7 billion in Q3 2023 and fell as low as $2.0 billion in Q1 2022.
- Historically, Inventory Average has averaged $2.4 billion across 5 years, with a median of $2.5 billion in 2025.
- Across the five-year window, Inventory Average gained 23.51% in 2023 and declined 11.04% in 2024, its largest moves.
- Year by year, Inventory Average stood at $2.3 billion in 2022, then increased by 14.2% to $2.7 billion in 2023, then retreated by 11.04% to $2.4 billion in 2024, then climbed by 4.38% to $2.5 billion in 2025, then grew by 1.72% to $2.5 billion in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 68.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.51 Bn |
| Dec 31, 2025 | 2.46 Bn |
| Sep 30, 2025 | 2.45 Bn |
| Jun 30, 2025 | 2.40 Bn |
| Mar 31, 2025 | 2.34 Bn |
| Dec 31, 2024 | 2.36 Bn |
| Sep 30, 2024 | 2.43 Bn |
| Jun 30, 2024 | 2.55 Bn |
| Mar 31, 2024 | 2.61 Bn |
| Dec 31, 2023 | 2.65 Bn |
| Sep 30, 2023 | 2.72 Bn |
| Jun 30, 2023 | 2.63 Bn |
| Mar 31, 2023 | 2.45 Bn |
| Dec 31, 2022 | 2.32 Bn |
| Sep 30, 2022 | 2.25 Bn |
| Jun 30, 2022 | 2.13 Bn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | 1.90 Bn |
| Sep 30, 2021 | 1.84 Bn |
| Jun 30, 2021 | 1.75 Bn |